-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PsOla0tcuarblRZeJR2SujYTnUpCANqhgGepy73NXjMdsMJS6boDUd71HIAIs+jk NIZ3ipgupdd0SNUjL9chtw== 0001104659-07-090139.txt : 20071220 0001104659-07-090139.hdr.sgml : 20071220 20071220142459 ACCESSION NUMBER: 0001104659-07-090139 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20071220 DATE AS OF CHANGE: 20071220 GROUP MEMBERS: AVIVA GROUP HOLDINGS LIMITED GROUP MEMBERS: AVIVA INSURANCE LIMITED GROUP MEMBERS: AVIVA INTERNATIONAL HOLDINGS LIMITED GROUP MEMBERS: AVIVA INTERNATIONAL INSURANCE LIMITED GROUP MEMBERS: AVIVA PLC GROUP MEMBERS: CGU INTERNATIONAL HOLDINGS B.V. GROUP MEMBERS: CYRTE FUND III C.V. GROUP MEMBERS: CYRTE INVESTMENTS GP III B.V. GROUP MEMBERS: DELTA LLOYD N.V. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Vivo Participacoes S.A. CENTRAL INDEX KEY: 0001071337 STANDARD INDUSTRIAL CLASSIFICATION: TELEPHONE COMMUNICATIONS (NO RADIO TELEPHONE) [4813] IRS NUMBER: 000000000 STATE OF INCORPORATION: D5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79126 FILM NUMBER: 071318823 BUSINESS ADDRESS: STREET 1: AV. ROQUE PETRONI JUNIOR, 1464 STREET 2: 4 ANDAR, LADO "A" CITY: SAO PAULO - SP STATE: D5 ZIP: 04707-000 BUSINESS PHONE: 011-55-11-5105-1182 MAIL ADDRESS: STREET 1: AV. ROQUE PETRONI JUNIOR, 1464 STREET 2: 4 ANDAR, LADO "A" CITY: SAO PAULO - SP STATE: D5 ZIP: 04707-000 FORMER COMPANY: FORMER CONFORMED NAME: TELESP CELLULAR HOLDING CO /ADR/ DATE OF NAME CHANGE: 19980930 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CYRTE INVESTMENTS BV CENTRAL INDEX KEY: 0001389684 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: FLEVOLAAN 41A STREET 2: 411 KC NAARDEN P.O. BOX 5081 CITY: NAARDEN STATE: P7 ZIP: 1401 AB BUSINESS PHONE: 31 35 695 9000 MAIL ADDRESS: STREET 1: FLEVOLAAN 41A STREET 2: 411 KC NAARDEN P.O. BOX 5081 CITY: NAARDEN STATE: P7 ZIP: 1401 AB SC 13D/A 1 a07-31740_2sc13da.htm SC 13D/A

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE
COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

 

SCHEDULE 13D/A

 

 

 

 

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

 

VIVO PARTICIPAÇOES S.A.

(Name of Issuer)

 

American Depositary Shares (as evidenced by American Depositary Receipts) each representing one share of Preferred Stock

(Title of Class of Securities)

 

928555S101

(CUSIP Number)

 

Gaylord Macnack

Flevolaan 41A

1411 KC NAARDEN

P.O. Box 5081

1410 AB NAARDEN

The Netherlands

+31 35 695 9000

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

Copy to:

 

Jeff Hendrickson, Esq.

Herbert Smith LLP

Exchange House

Primrose Street

London EC2A 2HS

United Kingdom

+44 20 7374 8000

 

December 19, 2007

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 



 

CUSIP No. 928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Cyrte Investments B.V.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
The Netherlands

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

2



 

CUSIP No. 928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Cyrte Investments GP III B.V.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
The Netherlands

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

3



 

CUSIP No. 928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Cyrte Fund III C.V.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
OO

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
The Netherlands

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

4



 

CUSIP No. 928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Aviva plc

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
England and Wales

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

5



 

CUSIP No.  928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Aviva Group Holdings Limited

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
England and Wales

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

6



 

CUSIP No.  928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Aviva International Insurance Limited

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
England and Wales

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

7



 

CUSIP No.  928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Aviva Insurance Limited

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Scotland

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

8



 

CUSIP No.  928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Aviva International Holdings Limited

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
England and Wales

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

9



 

CUSIP No.  928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
CGU International Holdings B.V.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
The Netherlands

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

10



 

CUSIP No. 928555S101

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Delta Lloyd N.V.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 x

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
The Netherlands

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
61,738,085(1)

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
61,738,085(1)

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,738,085

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.73% (2)

 

 

14.

Type of Reporting Person (See Instructions)
OO

 


(1) The Reporting Persons collectively own 61,738,085 American Depository Shares each representing one share of Preferred Stock of Vivo Participaçoes S.A.

 

(2) The calculation of the foregoing percentage is based on 917,186,080 shares of Preferred Stock of Vivo Participaçoes S.A. outstanding as of September 30, 2007, as reported on the issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007.

 

11



 

Item 1.

Security and Issuer

 

This Amendment No. 2 to the statement on Schedule 13D (this “Amendment”) filed with the Securities and Exchange Commission on April 30, 2007, as amended on September 27, 2007, relates to 61,738,085 American Depository Shares, representing 61,738,085 shares of Preferred Stock (the “Shares”) of Vivo Participaçoes S.A.  (the “Company”).  The Company’s principal offices are located at Av. Roque Petroni Jr., No. 1464, 6th floor-part, “B” Building, 04707-000-Sao Paolo, SP, Federative Republic of Brazil.

 

 

 

Item 2.

Identity and Background

(a), (b) and (c) This Amendment is being filed jointly by (i) Aviva plc, a public limited company organized under the laws of England and Wales, (ii) Aviva Group Holdings Limited, a limited liability company organized under the laws of England and Wales; (iii) Aviva International Insurance Limited, a limited liability company organized under the laws of England and Wales; (iv) Aviva Insurance Limited, a limited liability company organized under the laws of Scotland; (v) Aviva International Holdings Limited, a limited liability company organized under the laws of England and Wales; (vi) CGU International Holdings B.V., a limited liability company organized under the laws of The Netherlands; (vii) Delta Lloyd N.V., a limited liability company organized under the laws of The Netherlands; (viii) Cyrte Investments B.V. (“Cyrte Investments”), a limited liability company organized under the laws of The Netherlands;  (ix) Cyrte Investments GP III B.V. (“Cyrte Investments GP”), a limited liability company organized under the laws of The Netherlands; and (x) Cyrte Fund III C.V. (“Cyrte Fund”), a limited partnership organized under the laws of The Netherlands (collectively, the “Reporting Persons”).  Aviva plc, Aviva Group Holdings Limited, Aviva International Insurance Limited, Aviva Insurance Limited, Aviva International Holdings Limited and CGU International Holdings B.V. are referred to herein as the “Aviva Reporting Persons”.

 

Aviva plc owns all of the outstanding share capital of Aviva Group Holdings Limited.  Aviva Group Holdings Limited owns all of the outstanding share capital of Aviva International Insurance Limited.  Aviva International Insurance Limited owns all of the outstanding share capital of Aviva Insurance Limited.  Aviva Insurance Limited owns all of the outstanding share capital of Aviva International Holdings Limited.  Aviva International Holdings Limited owns all of the outstanding share capital of CGU International Holdings B.V.  CGU International Holdings B.V. owns 92% of the outstanding share capital of Delta Lloyd N.V. Delta Lloyd N.V. owns 85% of the share capital of Cyrte Investments. Cyrte Investments is the manager of the investment portfolio held by Cyrte Fund and owner of all of the outstanding capital stock of Cyrte Investments GP.  Cyrte Investments GP is the general partner of Cyrte Fund.

 

The name, business address, business activity and present principal occupation or employment of each director, officer or general partner of the Reporting Persons are set forth in Schedule I hereto, which is incorporated herein by reference.

 

The principal business of each of the Aviva Reporting Persons and Delta Lloyd N.V. is insurance services. The principal business of Cyrte Investments is investment management.  Cyrte Investments GP’s principal business is to act as the general partner of Cyrte Fund.  Cyrte Fund is an investment fund; its principal business is to invest in listed and non-listed equity securities in the technology, media and telecommunication sectors. 

 

(d) During the last five years, none of the Reporting Persons, nor, to the knowledge of the Reporting Persons, any of persons listed on Schedule I hereto, has been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors).

 

(e) During the last five years, none of the Reporting Persons, nor, to the knowledge of the Reporting Persons, any of persons listed on Schedule I hereto, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

(f) The citizenship of each director or general partner of the Reporting Persons who is a natural person is set forth in Schedule I hereto, which is incorporated herein by reference.

 

 

Item 3.

Source and Amount of Funds or Other Consideration

 

On December 19, 2007, Cyrte Investments GP (for the benefit of Cyrte Fund, and acting solely in its capacity as General Partner of Cyrte Fund) received 48,372,876 American Depository Shares, representing 48,372,876 Shares of the Company, from Cyrte Investments GP I B.V. (for the benefit of CF I Invest C.V. (formerly named Cyrte Fund I C.V.), and acting solely in its capacity as General Partner of CF I Invest C.V.), in consideration for a limited partner interest in Cyrte Fund, and also received 13,365,209 American Depository Shares, representing 13,365,209 Shares of the Company, from Stichting Pensioenfonds voor de Gezondheid, Geestelijke en Maatschappelijke belangen (“PGGM”), in consideration for a limited partner interest in Cyrte Fund.

 

12



 

Item 4.

Purpose of Transaction

The Reporting Persons have acquired the Shares of the Company for investment purposes.  The Reporting Persons intend to assess their investment in the Company from time to time on the basis of various factors, including, without limitation, the Company’s business, financial condition, results of operations and prospects, general economic, market and industry conditions, as well as other developments and other investment opportunities.  Depending upon the foregoing factors or any other factors deemed relevant to the Reporting Persons, they may acquire additional shares in the Company, or dispose of all or part of the shares of the Company, in open market transactions, privately negotiated transactions or otherwise. Any acquisition or disposition may be effected by the Reporting Persons at any time without prior notice.  The Reporting Persons may engage in communications from time to time with one or more stockholders, officers or directors of the Company regarding the Company’s operating performance, strategic direction or other matters that could result in or relate to, among other things, any of the matters set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

 

The Reporting Persons have, in the past, engaged in meetings and communications from time to time with the Company’s key personnel. These meetings and conversations were held for the purpose of better understanding the Company and its industry. In the future, the Reporting Persons may engage in communications from time to time with one or more stockholders, officers or directors of the Company regarding the Company’s operating performance, strategic direction or other matters that could result in or relate to, among other things, any of the matters set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

 

Except as described in this Amendment, none of the Reporting Persons has any present plan or proposal that relates to, or could result in, any of the events referred to in paragraphs (a) through (j), inclusive, of Item 4 of Schedule 13D. The Reporting Persons will, however, continue to review the business of the Company and, depending upon one or more of the factors referred to above, may in the future propose that the Company take one or more such actions.

 

 

Item 5.

Interest in Securities of the Issuer

 

(a) and (b) According to the Company’s current report on Form 6-K filed with the Securities and Exchange Commission on November 7, 2007, there were 917,186,000 Shares outstanding as of September 30, 2007.  Cyrte Investments GP directly owns interests in 61,738,085 Shares, which represents 6.73% of the Shares outstanding as of September 30, 2007.  None of the Aviva Reporting Persons, Delta Lloyd N.V., Cyrte Investments and Cyrte Fund directly own such Shares.  However each of the Aviva Reporting Persons, Delta Lloyd N.V., Cyrte Investments and Cyrte Fund may be deemed to be beneficial owners, as well as share the power to vote and dispose, of such Shares directly owned by Cyrte Investments GP by virtue of the fact that: Aviva plc owns all of the outstanding share capital of Aviva Group Holdings Limited, Aviva Group Holdings Limited owns all of the outstanding share capital of Aviva International Insurance Limited, Aviva International Insurance Limited owns all of the outstanding share capital of Aviva Insurance Limited, Aviva Insurance Limited owns all of the outstanding share capital of Aviva International Holdings Limited,  Aviva International Holdings Limited owns all of the outstanding share capital of CGU International Holdings B.V., CGU International Holdings B.V. owns 92% of the outstanding share capital of Delta Lloyd N.V.; Delta Lloyd N.V. owns 85% of the share capital of Cyrte Investments, Cyrte Investments is the manager of the investment portfolio held by Cyrte Fund and owner of all of the outstanding capital stock of Cyrte Investments GP and  Cyrte Investments GP is the general partner of Cyrte Fund.  Each of the Aviva Reporting Persons, Delta Lloyd N.V., Cyrte Investments and Cyrte Fund disclaims beneficial ownership of such Shares for all other purposes.

 

(c) During the past 60 days, none of the Reporting Persons has bought, sold or otherwise received Shares except in the transactions described in Item 3 hereto, or in Schedule II attached hereto, which is incorporated herein by reference.

 

(d) The limited partners of Cyrte Fund, being CFI Invest C.V., Delta Lloyd Levensverzekering N.V., Stichting Pensioenfonds ABP, and PGGM will have the benefit of any dividends from, or proceeds from the sale of, the Shares of the Company owned by Cyrte Investments GP, subject to certain fee arrangements.

 

(e) Not applicable.

 

13



 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

To the best knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any of the securities of the Company, including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

 

 

Item 7.

Material to Be Filed as Exhibits

 

Exhibit No.

 

Description

 

 

 

Exhibit 99.1

 

Agreement of Joint Filing among Cyrte Investments B.V., Cyrte Investments GP III B.V., Cyrte Fund III C.V., Aviva plc, Aviva Group Holdings Limited, Aviva International Insurance Limited, Aviva Insurance Limited, Aviva International Holdings Limited, CGU International Holdings B.V. and Delta Lloyd N.V., dated as of December 20, 2007.

 

 

 

Exhibit 99.2

 

Power of attorney granted on December 19, 2007 granting power of attorney to Mr Gaylord Macnack to sign on behalf of Cyrte Investments B.V. and Cyrte Investments GP III B.V. (also acting in its capacity as general partner of Cyrte Fund III C.V.).

 

14



 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

December 20, 2007

 

Date

/s/ Gaylord Macnack

 

Signature

Cyrte Investments B.V., by Gaylord Macnack, attorney-in-fact***

 

December 20, 2007

 

Date

/s/ Gaylord Macnack

 

Signature

Cyrte Investments GP III B.V., by Gaylord Macnack, attorney-in-fact***

 

December 20, 2007

 

Date

/s/ Gaylord Macnack

 

Signature

Cyrte Fund III C.V., by Gaylord Macnack, attorney-in-fact***

 

December 20, 2007

 

Date

/s/ Antoinette Sprenger

 

Aviva plc, by Antoinette Sprenger, attorney-in-fact**

 

December 20, 2007

 

Date

 

/s/ Antoinette Sprenger

 

Signature

Aviva Group Holdings Limited by Antoinette Sprenger, attorney-in-fact**

 

December 20, 2007

 

Date

/s/ Antoinette Sprenger

 

Signature

Aviva International Insurance Limited by Antoinette Sprenger, attorney-in-fact**

 

December 20, 2007

 

Date

/s/ Antoinette Sprenger

 

Signature

Aviva Insurance Limited by Antoinette Sprenger, attorney-in-fact**

 

December 20, 2007

 

Date

 

/s/ Antoinette Sprenger

 

Signature

Aviva International Holdings Limited by Antoinette Sprenger, attorney-in-fact**

 

December 20, 2007

 

Date

 

/s/ Antoinette Sprenger

 

Signature

CGU International Holdings B.V. by Antoinette Sprenger, attorney-in-fact**

 

December 20, 2007

 

Date

/s/ Antoinette Sprenger

 

Signature

Delta Lloyd N.V., by Antoinette Sprenger, attorney-in-fact**

 


** Signed pursuant to powers of attorney, dated October 2, 2007 and October 8, 2007, included as Exhibit 99.2 to Amendment No. 8 to the statement on Schedule 13D filed with the Securities and Exchange Commission on October 9, 2007 by the Reporting Persons are incorporated by reference herein.

 

*** Signed pursuant to power of attorney, dated December 19, 2007, included as Exhibit 99.2 to this Schedule 13D/A by the Reporting Persons.

 

15



 

SCHEDULE I

 

The name, business address, business activity, present principal occupation or employment and, if a natural person, citizenship of each director, officer or general partner of the Reporting Persons are set forth in Schedule I hereto, which is incorporated herein by reference.

 

Cyrte Investments B.V.

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Botman, Franciscus Johannes

 

Flevolaan 41A,
1411 KC Naarden,
P.O. Box 5081,
1401 AB Naarden,
The Netherlands

 

Director
(
bestuurder)
and Chairman of Management Board

 

Director
(bestuurder)

 

The Netherlands

Aardoom, Japhet Pieter

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Executive Director

 

Executive Director

 

The Netherlands

Otto, Alex Hendrikus

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Executive Director

 

Executive Director

 

The Netherlands

Hoek, Nicolaas Willem

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board
Director

 

The Netherlands

Kok, Petrus Jacobus Wilhelmus Gerardus

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board
Director

 

The Netherlands

Krant, Joop

 

Dreeftoren 5th floor
Haaksbergweg 11
1101 BP Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board
Director

 

The Netherlands

 

Cyrte Investments GP III B.V.

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Cyrte Investments B.V.

 

Flevolaan 41A,
411 KC Naarden,
P.O. Box 5081,
1401 AB Naarden,
The Netherlands

 

Investment
management

 

Investment management; sole director (bestuurder) of Cyrte Investments GP III B.V.

 

Not applicable

 

Cyrte Fund III C.V.

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Cyrte Investments GP III B.V.

 

Flevolaan 41A,
411 KC Naarden,
P.O. Box 5081,
1401 AB Naarden,
The Netherlands

 

Investment
management

 

Investment management; general partner of Cyrte Fund III C.V.

 

Not applicable

 

Aviva plc

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Arora, Nikesh

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Non exec. Director

 

Non exec. Director

 

United States

de la Dehesa Romero, Guillermo

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Non exec. Director

 

Non exec. Director

 

Spain

Dik, Wim

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Senior Independent Director

 

Senior Independent Director

 

The Netherlands

Francis, Mary, Elizabeth

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Non exec. Director

 

Non exec. Director

 

United Kingdom

Goeltz, Richard, Karl

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Non exec. Director

 

Non exec. Director

 

United States

Moss, Andrew, John

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Piwnica, Carole

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Non exec. Director

 

Non exec. Director

 

Belgium

Scott, Philip, Gordon

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Sharman, Colin, Morven

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Chairman

 

Chairman

 

United Kingdom

Walls, John, Russell, Fotheringham

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Non exec. Director

 

Non exec. Director

 

United Kingdom

Machell, Simon Christopher

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Executive Committee Member

 

Executive Committee Member

 

United Kingdom

Ainley, John

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Executive Committee Member

 

Executive Committee Member

 

United Kingdom

Godlasky, Thomas

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Executive Committee Member

 

Executive Committee Member

 

United States

Dromer, Alain

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Executive Committee Member

 

Executive Committee Member

 

France

Hodges, Mark, Steven

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Executive Committee Member

 

Executive Committee Member

 

United Kingdom

Mayer, Igal, Mordeciah

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Executive Committee Member

 

Executive Committee Member

 

United States

Sahay, Anupam

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Executive Committee Member

 

Executive Committee Member

 

India

 



 

Aviva Group Holdings Limited

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Hodges, Mark, Steven

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Mayer, Igal, Mordeciah

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United States

Moss, Andrew, John

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Sahay, Anupam

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

India

Scott, Philip, Gordon

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

 

Aviva International Insurance Limited

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Hodges, Mark, Steven

 

St Helen’s,
1Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Mayer, Igal, Mordeciah

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United States

Moss, Andrew, John

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Sahay, Anupam

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

India

Scott, Philip, Gordon

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

 

Aviva Insurance Limited

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Hodges, Mark, Steven

 

Pitheavlis,
Perth PH2 0NH

 

Director

 

Director

 

United Kingdom

Mayer, Igal, Mordeciah

 

Pitheavlis,
Perth PH2 0NH

 

Director

 

Director

 

United States

Moss, Andrew, John

 

Pitheavlis,
Perth PH2 0NH

 

Director

 

Director

 

United Kingdom

Sahay, Anupam

 

Pitheavlis,
Perth PH2 0NH

 

Director

 

Director

 

India

Scott, Philip, Gordon

 

Pitheavlis,
Perth PH2 0NH

 

Director

 

Director

 

United Kingdom

 



 

Aviva International Holdings Limited

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Hodges, Mark, Steven

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Mayer, Igal, Mordeciah

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United States

Moss, Andrew, John

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Sahay, Anupam

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

India

Scott, Philip, Gordon

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

 

CGU International Holdings B.V.

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Harris, Timothy

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Jones, Edward, Graham

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

Moss, Andrew, John

 

St Helen’s,
1 Undershaft,
London EC3P 3DQ

 

Director

 

Director

 

United Kingdom

 

Delta Lloyd N.V.

 

Name

 

Business address

 

Business activity

 

Present principal
occupation or
employment

 

Citizenship

Hoek, Nicolaas Willem

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Executive Director

 

Executive Director

 

The Netherlands

Kok, Petrus Jacobus Wilhelmus Gerardus

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Executive Director

 

Executive Director

 

The Netherlands

Medendorp, Paul Kerst

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Executive Director

 

Executive Director

 

Germany

Raué, Hendrik Herman

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Executive Director

 

Executive Director

 

The Netherlands

van der Burg, Vincent Arthur Maria

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board Director

 

The Netherlands

Kottman, René Herman Philip Willem

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board Director

 

The Netherlands

Smits, Marcellinus Hermanus Maria

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board Director

 

The Netherlands

Boumeester, Pamela Gertrude

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board Director

 

The Netherlands

Haars, Jan Gerard

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board Director

 

The Netherlands

Fischer, Eric Jacob

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board Director

 

The Netherlands

Moss, Andrew John

 

Amstelplein 6,
1096 BC Amsterdam,
The Netherlands

 

Supervisory Board Director

 

Supervisory Board Director

 

United Kingdom

 



 

SCHEDULE II

 

All of the Shares of the Company acquired and sold as described in the table below were acquired and sold by Cyrte Investments GP I B.V. in open market transactions prior to the transfer to Cyrte Investments GP, as described in Item 3.

Trade Date

 

Shares Acquired or Sold

 

Shares Price (USD)

 

October 4, 2007

 

125,000

 

4.5997

 

October 5, 2007

 

100,000

 

4.6500

 

October 11, 2007

 

30,793

 

5.0500

 

October 12, 2007

 

65,500

 

5.1457

 

October 15, 2007

 

125,000

 

5.1385

 

October 16, 2007

 

125,000

 

5.1503

 

October 22, 2007

 

-51,100

 

5.8018

 

October 23, 2007

 

-403,500

 

5.9169

 

November 1, 2007

 

44,670

 

5.6500

 

November 5, 2007

 

250,000

 

5.5500

 

November 9, 2007

 

1,597,700

 

5.2467

 

 

 

 

 

 

 

Bought in open market

 

2,009,063

 

 

 

 


EX-99.1 2 a07-31740_2ex99d1.htm AGREEMENT OF JOINT FILING... DATED AS OF DECEMBER 20, 2007.

EXHIBIT 99.1

 

CUSIP NO. 92855S101

 

AGREEMENT OF JOINT FILING

 

The undersigned hereby agree that they are filing jointly pursuant to Rule 13d-1(k)(1) of the Securities and Exchange Act of 1934, as amended, with respect to the shares of Common Stock, par value $0.001 per share, of Terremark Worldwide, Inc.   Each of the undersigned further agrees and acknowledges that it shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained herein, but shall not be responsible for completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.

 

 

DATED: December 20, 2007

REPORTING PERSON:

 

 

 

 

Cyrte Investments B.V.

 

 

/s/ Gaylord Macnack

 

 

By: Gaylord Macnack, attorney-in-fact***

 

 

 

 

 

Cyrte Investments GP III B.V.

 

 

/s/ Gaylord Macnack

 

 

By: Gaylord Macnack, attorney-in-fact***

 

 

 

 

 

Cyrte Fund III C.V.

 

 

/s/ Gaylord Macnack

 

 

By: Gaylord Macnack, attorney-in-fact***

 

 

 

 

 

Aviva plc

 

 

/s/ Antoinette Sprenger

 

 

By: Antoinette Sprenger, attorney-in-fact**

 

 

 

 

 

Aviva Group Holdings Limited

 

 

/s/ Antoinette Sprenger

 

 

By: Antoinette Sprenger, attorney-in-fact**

 

 

 

 

 

Aviva International Insurance Limited

 

 

/s/ Antoinette Sprenger

 

 

By: Antoinette Sprenger, attorney-in-fact**

 

 

 

 

 

Aviva Insurance Limited

 

 

/s/ Antoinette Sprenger

 

 

By: Antoinette Sprenger, attorney-in-fact**

 

 

 

 

 

Aviva International Holdings Limited

 

 

/s/ Antoinette Sprenger

 

 

By: Antoinette Sprenger, attorney-in-fact**

 

 

 

 

CGU International Holdings B.V.

 

 

/s/ Antoinette Sprenger

 

 

By: Antoinette Sprenger, attorney-in-fact**

 

 

 

 

 

Delta Lloyd N.V.

 

 

/s/ Antoinette Sprenger

 

 

By: Antoinette Sprenger, attorney-in-fact**

 

 


** Signed pursuant to powers of attorney, dated October 2, 2007 and October 8, 2007, included as Exhibit 99.2 to Amendment No. 8 to the statement on Schedule 13D filed with the Securities and Exchange Commission on October 9, 2007 by the Reporting Persons.

 

*** Signed pursuant to power of attorney, dated December 19, 2007, included as Exhibit 99.2 to this Schedule 13D/A by the Reporting Persons.


EX-99.2 3 a07-31740_2ex99d2.htm POWER OF ATTORNEY GRANTED ON DECEMBER 19, 2007...

EXHIBIT 99.2

 

THIS POWER OF ATTORNEY is granted on 19 December 2007,

 

(1)                                 Cyrte Investments B.V. (“Cyrte”) and Cyrte Investments GP III B.V. (also acting in its capacity of general partner of Cyrte Fund III C.V.) (“Cyrte GP”) hereby grant power of attorney to Mr. Gaylord Macnack (the “Attorney”) individually with full power of substitution to:

 

(a)                                           sign on behalf of Cyrte and Cyrte GP in the form as the Attorney may approve any filing and notification of any interest in listed securities that are required under applicable rules and regulation in any relevant jurisdiction, including without limitation Brazil, Germany, Greece, the United Kingdom and the United States of America (the “Filings”);

 

(b)                                          sign on behalf of Cyrte and Cyrte GP in the form as the Attorney may approve any further documents, agreements or deeds as may be ancillary, necessary or useful in connection with the execution or performance of the Filings; and

 

(c)                                           perform all acts as in the opinion of the Attorney shall be necessary or useful in connection with the preparation, execution or performance of the Filings and of the transactions contemplated thereby including acts of disposition (the “Power of Attorney”).

 

(2)                                 Cyrte nor Cyrte GP shall make any claim against the Attorney in respect of any act that is lawfully done by the Attorney under the Power of Attorney.

 

(3)                                 Cyrte shall indemnify and hold the Attorney harmless against any claims, actions or proceedings made against the Attorney and against any damages, costs and expenses that the Attorney may suffer or incur as a result of or in connection with any act that is lawfully done by the Attorney under the Power of Attorney.

 

(4)                                 Cyrte and Cyrte GP declare that this Power of Attorney also applies in situations where the Attorney also acts as a counterparty of Cyrte or Cyrte GP or as a representative of a counterparty of Cyrte or Cyrte GP (Selbsteintritt).

 

(5)                                 This Power of Attorney is governed by the laws of the Netherlands.

 

Cyrte Investments B.V.

Cyrte Investments GP III B.V.

 

(also acting in its capacity of
general partner of Cyrte Fund
III C.V
)

 

 

 

 

By:

F.J. Botman

 

By:

Cyrte Investments B.V.

 

Title: director

By:

F.J. Botman

 

 

Title: director

 


-----END PRIVACY-ENHANCED MESSAGE-----